Autoscope Q2 Earnings Rise Y/Y as Lower Costs Offset Revenue Dip

Shares of Autoscope Technologies Corporation AATC have gained 2.70% since reporting second-quarter 2026 results, outperforming the S&P 500 index’s decline of 0.10%. Over the past month, the stock has advanced 6.60% compared with the S&P 500’s 1.50% return.

Second-quarter revenues declined 2.20% to $2.79 million from $2.85 million a year earlier. Earnings per share rose to 15 cents from 14 cents in the prior-year quarter, while net income increased 9.30% to $0.84 million from $0.77 million. The differing direction of the top and bottom lines reflected lower operating expenses and a reduced income-tax provision, which more than offset weaker revenues and gross profit.

For the first six months, revenues fell 2.90% to $4.90 million, net income increased 2.40% to $1.16 million, and earnings were 21 cents as a modest increase in weighted-average shares offset higher earnings.

Autoscope Technologies Corporation Price, Consensus and EPS Surprise

Autoscope Technologies Corporation price-consensus-eps-surprise-chart | Autoscope Technologies Corporation Quote

Other Key Metrics

Royalty revenues, the company’s dominant revenue source, decreased 4.90% to $2.68 million from $2.82 million because of lower sales volume. Product sales climbed to $0.11 million from $0.03 million, lifting their share of quarterly revenues to 3.80% from 1.10%. Gross profit decreased to $2.67 million from $2.80 million, and the gross margin narrowed to 95.80% from 98.20%. The product gross margin improved sharply to 15% from negative 61.30%, while the royalty gross margin eased to 99% from 100%.

Operating expenses fell 3.90% to $1.61 million. Selling, general and administrative expenses declined 5.60% to $0.94 million, while research and development expenses slipped 1.30% to $0.67 million. Operating income decreased to $1.06 million from $1.13 million, and non-GAAP operating income fell to $1.16 million from $1.20 million. However, the net margin expanded to 30.20% from 27%, aided by income-tax expenses declining to $0.24 million from $0.34 million.

Cash and cash equivalents rose to $1.58 million as of June 30 from $0.74 million as of Dec. 31, 2025, while debt and equity investments totaled $1.08 million. The first-half operating cash flow nevertheless fell to $1.71 million from $2.87 million due mainly to less favorable working-capital changes, including lower receivables collections and smaller inventory reductions.

Management said that cash, investments and operating cash flow should cover foreseeable needs. A $1.46-million mortgage balance is due Dec. 10, 2026, and the company plans to refinance it before maturity.

Factors Behind the Results

The royalty decline reflected lower sales volume. Higher IntelliSight and Autoscope Analytics sales, neither of which had comparable revenues in the prior-year quarter, drove the product-sales increase. That benefit was partly offset by the absence of OptiVu and Wrong Way sales in the latest quarter. Gross margin pressure included amortization related to capitalized OptiVu software development. Low product volume and fixed software-amortization costs also continued to constrain product profitability.

Lower consulting fees and reduced fees associated with closing foreign entities drove the SG&A decline, partly offset by higher salaries and benefits following annual merit increases. The tax provision benefited from the absence of taxes related to foreign-entity closures that were recorded in the second quarter of 2025. Those cost and tax improvements explain why net income increased despite lower revenues, gross profit and operating income.

Management Commentary

CEO Andy Markese characterized the quarter as evidence of the royalty business’s durability and disciplined strategy execution. He said that Autoscope expanded OptiVu’s capabilities and deepened collaboration with a key strategic channel partner to support growth. Early Autoscope Analytics engagements also provided encouraging indications that the technology could create value beyond the traditional royalty business, although management emphasized that the initiative remains at an early stage. The company issued no quantitative earnings or revenue guidance, but Markese said that it was positioned to execute its strategy through the rest of 2026.

Other Developments

During the quarter, Autoscope decided to discontinue its legacy Wrong Way product, with end-of-life set for Dec. 31, 2026. Management said that the move would redirect engineering resources toward growth opportunities aligned with its longer-term strategy. Separately, the board declared a quarterly cash dividend of $0.15 per share, payable Aug. 27 to shareholders of record at the close of business on Aug. 20.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research